Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artemisia tea infusion is a botanical drug preparation derived from the dried leaves and twigs of the Artemisia species, specifically *Artemisia annua* and *Artemisia afra*. It is primarily investigated for its antimalarial properties, specifically for the eradication of *Plasmodium* carriage in asymptomatic individuals to reduce malaria transmission reservoirs. While *A. annua* contains the potent sesquiterpene lactone artemisinin, *A. afra* contains negligible amounts, suggesting that other phytochemical constituents within the plant matrix contribute to its anti-parasitemic and gametocidal effects. The drug is administered as a hot water infusion and has been evaluated in Phase 2 clinical trials in Cameroon, sponsored by the Académie de recherche et d'enseignement supérieur (ARES).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Artemisia tea infusion.